HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

This study aims to retrospectively analyze the HER2 expression of gynecological malignant tumors in Chongqing by immunohistochemical detection, and explore the correlation between HER2 level, therapy response and prognosis based on patient clinical information.

Inclusion Criteria:

• Patients with primary gynecological malignant tumor confirmed by histopathology
• Women aged 18-75
• The expected survival time is greater than 12 weeks
• KPS > 60, ECOG score is 0-2
• All subjects voluntarily joined this study with informed consents, and had good compliance of follow-up

Exclusion Criteria:

• Pregnant and lactating women
• Suffering from other malignant tumors in the past 5 years
• Patients who are not suitable for this study according to the investigator's judgment